TORRENT PHARMACEUTICALS L Financial Ratios
TORNTPHARM · Healthcare · Current price ₹4,978
P/E ratio
77.9x
P/B ratio
18.7x
ROE
27.4%
ROCE
15.0%
Debt / Equity
1.69
Dividend yield
0.8%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 77.9x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 18.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 27.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 15.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.69 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with TORRENT PHARMACEUTICALS L's latest numbers.
TORRENT PHARMACEUTICALS L profitability
TORRENT PHARMACEUTICALS L generates a return on equity of 27.4% and a return on capital employed of 15.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.69 and a P/E of 77.9x, TORRENT PHARMACEUTICALS L is carrying meaningful debt. Our overall business-quality score for the company is 5.0 / 10.
Understand the ratios
More on TORRENT PHARMACEUTICALS L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.